Kevin Caliendo
Stock Analyst at UBS
(4.28)
# 413
Out of 5,182 analysts
209
Total ratings
66.67%
Success rate
10.33%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Neutral | $210 → $220 | $196.63 | +11.89% | 18 | Apr 22, 2026 | |
| MCK McKesson | Maintains: Buy | $1,012 → $1,000 | $828.32 | +20.73% | 18 | Apr 22, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $5 | $3.47 | +44.09% | 4 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Buy | $48 → $57 | $45.23 | +26.02% | 2 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $12 | $7.27 | +65.06% | 7 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Neutral | $79 → $87 | $77.20 | +12.69% | 7 | Feb 25, 2026 | |
| ALGN Align Technology | Maintains: Neutral | $175 → $185 | $184.70 | +0.16% | 20 | Feb 5, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $17 → $16 | $11.96 | +33.78% | 13 | Feb 3, 2026 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $25 | $26.77 | -6.61% | 5 | Feb 3, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $20.95 | +0.24% | 9 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $97 | $78.36 | +23.79% | 11 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $77 → $79 | $69.78 | +13.21% | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $380 → $415 | $310.16 | +33.80% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.28 | +75.44% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $202.34 | +8.73% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $354.69 | +21.23% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $263.43 | +21.47% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $179.22 | -5.14% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $6.14 | +46.58% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $282.58 | +38.01% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $223.62 | +11.80% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $43.50 | +81.61% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $356.13 | +61.46% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $225.34 | -20.12% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $5.85 | +1,130.77% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $31.26 | -64.81% | 4 | May 4, 2021 |
Quest Diagnostics
Apr 22, 2026
Maintains: Neutral
Price Target: $210 → $220
Current: $196.63
Upside: +11.89%
McKesson
Apr 22, 2026
Maintains: Buy
Price Target: $1,012 → $1,000
Current: $828.32
Upside: +20.73%
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $3.47
Upside: +44.09%
Medline
Feb 26, 2026
Maintains: Buy
Price Target: $48 → $57
Current: $45.23
Upside: +26.02%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $7.27
Upside: +65.06%
Henry Schein
Feb 25, 2026
Maintains: Neutral
Price Target: $79 → $87
Current: $77.20
Upside: +12.69%
Align Technology
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $184.70
Upside: +0.16%
DENTSPLY SIRONA
Feb 3, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $11.96
Upside: +33.78%
Envista Holdings
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $26.77
Upside: -6.61%
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $20.95
Upside: +0.24%
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $78.36
Upside: +23.79%
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $69.78
Upside: +13.21%
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $310.16
Upside: +33.80%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.28
Upside: +75.44%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $202.34
Upside: +8.73%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $354.69
Upside: +21.23%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $263.43
Upside: +21.47%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $179.22
Upside: -5.14%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.14
Upside: +46.58%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $282.58
Upside: +38.01%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $223.62
Upside: +11.80%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $43.50
Upside: +81.61%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $356.13
Upside: +61.46%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $225.34
Upside: -20.12%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $5.85
Upside: +1,130.77%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $31.26
Upside: -64.81%